Drug class
First-generation H1 antihistamine; antiallergic and antipruritic agent
Mechanism of action
Antagonises histamine H1 receptors and reduces histamine-mediated allergic symptoms including itching and vascular permeability. Sedative and anticholinergic effects may occur.
General use cases
- Symptomatic treatment of allergic rhinitis, urticaria and pruritus in countries where clocinizine products remain authorised; marketed availability is limited and jurisdiction-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
